Artificial Intelligence in Drug Discovery and Pharmacotherapy

Artificial intelligence in drug discovery and pharmacotherapy leverages machine learning, deep learning, and computational modeling to accelerate identification of novel drug candidates, optimize dosing strategies, and predict therapeutic outcomes. AI algorithms analyze large-scale datasets from genomics, proteomics, metabolomics, electronic health records, and clinical trials to identify potential targets, predict drug-target interactions, and evaluate safety profiles. Current challenges include data heterogeneity, model interpretability, integration with regulatory frameworks, and ensuring clinical validation of AI-generated predictions. Emerging trends involve AI-assisted personalized medicine, adaptive clinical trial design, and predictive pharmacovigilance, enabling more precise and individualized therapy. Nanotechnology-based AI platforms facilitate high-throughput screening and real-time monitoring of drug delivery and efficacy. AI also contributes to early detection of adverse drug reactions, optimization of combination therapies, and repurposing of existing drugs for new indications. Regulatory agencies are developing guidelines to ensure validation, reliability, and ethical use of AI in pharmacotherapy, including transparency, reproducibility, and patient data privacy. Integration of AI with laboratory automation, omics technologies, and computational biology reduces time and cost of drug development while enhancing predictive accuracy and decision-making. By combining molecular insights, patient-specific data, and advanced computational tools, AI is transforming modern pharmacotherapy, enabling precision medicine, improving therapeutic efficacy, minimizing adverse effects, and guiding the development of innovative drugs and delivery systems. The field represents a critical convergence of technology, pharmacology, and regulatory science, addressing complex challenges in drug discovery and clinical application while shaping the future of biomedicine.

    Related Conference of Artificial Intelligence in Drug Discovery and Pharmacotherapy

    December 04-05, 2025

    9th International Conference on Protein Engineering

    Paris, France
    December 11-12, 2025

    7th International Conference on Biochemistry

    Prague, Czech Republic
    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    March 23-24, 2026

    29th European Biotechnology Congress

    Rome, Italy
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE

    Artificial Intelligence in Drug Discovery and Pharmacotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in